Fresenius CEO’s remarks at Davos26 about the need for a “fundamental rethink” in healthcare delivery are less a visionary call to action and more a glaring indictment of how stagnant…
The European Medicines Agency’s decision to host the Veterinary Medicines Info Day in a purely online format reflects both the evolving digital landscape and a cautious approach to stakeholder engagement.…
The recent survey by Imprivata highlighting the enthusiasm among healthcare IT leaders for passwordless authentication is both unsurprising and deeply telling. It underscores a growing awareness that traditional password-based security…
The European Medicines Agency’s decision to host the Product Management Service (PMS) information day as a half-day online broadcast is emblematic of the ongoing tension between accessibility and depth in…
PathoCare Holdings’ recent announcement of a $1.75 billion valuation via a private third-party tender offer is more than just a financial milestone—it’s a clear indicator of evolving investor confidence in…
The medical device industry is at a pivotal crossroads as we look toward 2026, and the seismic shifts in 2025 are more than just fleeting headlines—they are harbingers of a…
Neurable’s recent $35 million Series A funding round is more than just a financial milestone—it represents a pivotal moment for the brain-computer interface (BCI) sector, especially as it inches closer…
The European Medicines Agency’s upcoming multi-stakeholder workshop on cardiovascular medicines and medical devices, scheduled for July 2026, is positioned as a pivotal moment for fostering innovation within the EU. However,…
The upcoming EMA workshop on cardiovascular medicines and devices, scheduled for July 2026, positions itself as a platform for fostering innovation within the EU. However, from an industry standpoint, the…
The European Medicines Agency’s announcement of the Clinical Trials Information System (CTIS) sponsor end user training program, scheduled for March 2026, is a critical milestone in the ongoing effort to…